Isto Technologies

company

About

ISTO Technologies is an orthobiologics firm developing biologic products to regenerate and restore function to damaged cartilage and bone.

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.20M
Industries
Biotechnology,Information Technology,Medical Device
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Close

ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.95M
Isto Technologies has raised a total of $1.95M in funding over 2 rounds. Their latest funding was raised on Jul 29, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 29, 2015 Grant $1.20M 1 Detail
Aug 14, 2002 Grant $750K 1 Detail

Investments

Number of Investments
Number of Lead Investments
5
0
Isto Technologies has made 5 investments. Their most recent investment was on May 25, 2022, when Finnt raised $3.50M.
Date Company Name
Round Money Raised Industry Lead Investor
May 25, 2022 Finnt
Seed $3.50M Cryptocurrency
Mar 2, 2022 Polymer Labs
Seed $3.60M Blockchain
Jun 9, 2021 Eight Sleep
Angel Consumer Electronics
Apr 1, 2021 Goody
Series A $13.10M Consumer
Mar 10, 2021 Clara
Pre-seed $3.50M Credit Cards

Investors

Number of Lead Investors
Number of Investors
1
Isto Technologies is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant